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The Journal of Immunology
Pleiotropic Impacts of Macrophage and Microglial Deficiency
on Development in Rats with Targeted Mutation of the
Csf1r Locus
Clare Pridans,*,† Anna Raper,* Gemma M. Davis,* Joana Alves,* Kristin A. Sauter,*
Lucas Lefevre,* Tim Regan,* Stephen Meek,* Linda Sutherland,* Alison J. Thomson,*,‡
Sara Clohisey,* Stephen J. Bush,*,x Rocı´o Rojo,*,1 Zofia M. Lisowski,* Robert Wallace,{
Kathleen Grabert,* Kyle R. Upton,*,‖ Yi Ting Tsai,# Deborah Brown,* Lee B. Smith,#,**
Kim M. Summers,†† Neil A. Mabbott,* Pedro Piccardo,* Michael T. Cheeseman,*
Tom Burdon,* and David A. Hume†,††
We have produced Csf1r-deficient rats by homologous recombination in embryonic stem cells. Consistent with the role of Csf1r in
macrophage differentiation, there was a loss of peripheral blood monocytes, microglia in the brain, epidermal Langerhans cells,
splenic marginal zone macrophages, bone-associated macrophages and osteoclasts, and peritoneal macrophages. Macrophages of
splenic red pulp, liver, lung, and gut were less affected. The pleiotropic impacts of the loss of macrophages on development of
multiple organ systems in rats were distinct from those reported in mice. Csf1r2/2 rats survived well into adulthood with postnatal
growth retardation, distinct skeletal and bone marrow abnormalities, infertility, and loss of visceral adipose tissue. Gene expres-
sion analysis in spleen revealed selective loss of transcripts associated with the marginal zone and, in brain regions, the loss of
known and candidate novel microglia-associated transcripts. Despite the complete absence of microglia, there was little overt
phenotype in brain, aside from reduced myelination and increased expression of dopamine receptor-associated transcripts in
striatum. The results highlight the redundant and nonredundant functions of CSF1R signaling and of macrophages in develop-
ment, organogenesis, and homeostasis. The Journal of Immunology, 2018, 201: 000–000.
R
esident macrophages are abundant in all tissues, where
they adapt to distinct niches and environments,
expressing specific genes to perform tissue-specific
homeostatic functions (reviewed in Ref. 1, 2). Macrophage
differentiation from progenitor cells, and many aspects of their
mature function, is controlled by two ligands, CSF1 and IL-34,
which both signal through the CSF1R. The biology of CSF1R and
its ligands is conserved from birds to mammals (3). Csf1r ex-
pression in adults is restricted to cells of the myeloid lineages,
and transcriptional regulation of the gene has been studied
extensively, both in vitro and with the use of transgenic mice,
chickens, and sheep (4–6).
In humans, mutations in the tyrosine kinase domain of CSF1R
have been associated with a neurodegenerative disease, autoso-
mal dominant, adult-onset leukoencephalopathy with axonal
spheroids and pigmented glia (ALSP, previously known as he-
reditary diffuse leukoencephalopathy with spheroids) (7). Disease-
associated mutant CSF1R isoforms can be expressed on the cell
surface but lack ligand-dependent kinase activity and probably act
as dominant negative repressors of the wild type allele (8).
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Targeted mutation of Csf1r in mice depleted tissue macrophages
from most organs and had pleiotropic impacts on growth and
development (9). The more penetrant phenotype of the receptor
mutation, compared with the natural mutation of the Csf1 ligand
in the Csf1op/op mouse, predicted the existence of the second li-
gand, IL-34 (9). Phenotypes of the Csf1 or Csf1r mutant mice
include increased bone density (osteopetrosis), abnormalities of
the sensory nervous system, global defects in brain development,
infertility, failure of pancreatic b cell development, and severe
postnatal growth retardation (reviewed in Ref. 10, 11). On the
original cross-bred background, around 50% of Csf1r2/2 mice
survived to weaning. On an inbred background, survival beyond
3 weeks was rare (12).
Rat models have been used extensively in the study of human
disease and are preferred to mice in areas of inflammation, de-
velopment, physiology, neurobiology, pharmacology, and behavior
(reviewed in Ref. 13). The use of rats has recently been
accelerated by the expanding availability of genetic modification
technologies via homologous recombination in embryonic stem
cells (ESC) and, more recently, CRISPR–Cas9 and other targeted
nucleases. This has led to a comeback of the rat in biomedical
research (14). Rats provide many experimental advantages over
mice such as larger sample volumes, higher resolution in vivo
imaging, improved performance in learning/memory behavioral
assays, easier surgical procedures, and physiological similarities
with humans (15). They are the model of choice in areas such as
diabetes, breast cancer, and chronic inflammatory and cardiovas-
cular diseases as well as age-related illnesses (reviewed in Ref.
16). Current knowledge of CSF1R biology in rats has been based
upon limited analysis of the toothless (tl/tl) mutation in the ligand
CSF1, focused largely upon the osteopetrotic phenotype in bone
(17). In this article, we report on the generation Csf1r2/2 rats by
homologous recombination in ESC and their detailed phenotypic
characterization. The results highlight significant differences in
CSF1R between species and suggest the rat may be a better pre-
dictive model for human macrophage biology.
Materials and Methods
Production of Csf1r2/2 rats
An EGFP-PGK-Neo cassette flanked by 2.2 kb 59 and 5 kb 39 homology
arms (Supplemental Fig. 1A) was introduced into ESC derived from a male
Dark Agouti rat [clone DAK31 (18) provided by Austin Smith] by elec-
troporation. Positive selection was provided by a PGK-Neo cassette, and
negative selection was provided by a diphtheria toxin-A chain cassette.
The diphtheria toxin-A chain cassette was placed upstream of the 59 ho-
mology arm and so was not incorporated into the genome. Csf1r gene-
targeted rat ESC clones were identified by 59 PCR screening and 39
Southern blot analysis. Of the 24 clones analyzed, 20 were positive at the
59 end for the targeted allele by PCR, and 18 were positive at the 39 end for
the targeted allele by Southern blot (Supplemental Fig. 1D, 1E). Fifty
percent of clones analyzed had normal karyotypes (data not shown), and
clone DAK31-C2 was used to generate the colony (Supplemental Fig. 1B).
All experiments were carried out under the authority of a U.K. Home
Office Project License under the regulations of the Animals (Scientific
Procedures) Act 1986. Approval was obtained from ethics committees of
The Roslin Institute and The University of Edinburgh. Csf1r2/2 rats were
produced by blastocyst injection as described in (19), except that Sprague–
Dawley females were used as both embryo donors and pseudo-pregnant
recipients. Genotyping and the 59 PCR screen of ESC clones was per-
formed by PCR using MyTaq HS DNA polymerase (Bioline) with the
primers forward: 59-GCTGCAGTCCCTTACATAGGTCTAC-39, reverse 1:
59-GGAGGTGCAGATGAACTTCAGG-39, and reverse 2: 59-AGCTTC-
CCCTGCCCTGAGAAG-39. Expected products were 3.5 and 2.9 kb for
the wild type and mutant Csf1r, respectively (Supplemental Fig. 1C).
39 Southern blot analysis of ESC clones
Genomic DNA (7.5 mg) from ESC clones were digested with Xbal and
used in Southern blot analysis as per standard procedures. The probe was
503 bp and spanned the third exon of rat Csf1r (Rat Genome Sequencing
Consortium 6.0/rn6, chr18:56,437,991–56,438,493).
Gene expression analysis
Livers and spleens were preserved in RNAlater (Invitrogen). Total RNA
was isolated in TRIzol (Invitrogen), followed by purification with an
RNeasy Mini kit (QIAGEN) according to instructions. cDNA synthesis
and quantitative real-time PCR (qRT-PCR) were performed as described in
(6). The oligonucleotides used are listed in Table I.
Radiographs and micro–computed tomography analysis of
bone architecture
Radiographs were produced at the Hospital for Small Animals located at the
Royal (Dick) School of Veterinary Studies (Easter Bush, U.K). Micro–
computed tomography (mCT) analysis was performed on formalin fixed
tibias and skulls using a SkyScan 1172 (Bruker) at a resolution of 17.22
mm with a 0.5-mm aluminum filter and four-frame averaging to improve
the signal to noise ratio of the images. The tibias were scanned using a
source voltage of 71 kV and a source current of 139 mA. To accommodate
the larger dimensions of the skulls, a double width acquisition mode was
used with a source voltage of 81 kV and a source current of 122 mA. An
exposure time of 1180 ms was used for all scans. The images were
reconstructed using NRecon v1.6.9 (Bruker) and analyzed using CTAn
v1.13.5 (Bruker) software.
Complete blood count analysis
Whole EDTA blood was analyzed as described in (20).
Serum biochemistry analysis
Serum was analyzed using the ILab 650 automated biochemistry analyzer
(Instrumentation Laboratory).
Flow cytometry
Blood was collected into EDTA tubes via cardiac bleeds and prepared using
Dako Uti-Lyse erythrocyte lysing solution according to instructions. Blood
was stained with AF647-labeled CSF1-Fc (6) and the following Abs:
CD32APC (Clone REA256, 1:40) and CD161APC (Clone REA227, 1:40)
from Miltenyi Biotec, B220PE (Clone His24, 1:400; eBioscience), CD4FITC
(Clone W3/25, 1:10; Bio-Rad Laboratories), CD3AF488 (Clone 1F4, 1:200),
and SIRPaPE (Clone OX-41, 1:400) from BioLegend. Myelin-depleted
single-cell suspensions of brain were prepared as described in (21), ex-
cept rats were perfused with physiological saline and heparin and then
stained with CD45EF450 (Clone OX1, 1:200; eBioscience) and CD11b/cAF647
(Clone OX-42, 1:500; BioLegend). Peritoneal cavity cells were isolated as
described in (22) and stained with SIRPaPE and CD11b/cAF488 as de-
scribed above. Isotype controls were used for all flow cytometry data. Cells
were analyzed by flow cytometry on a FACSCalibur, LSRFortessa X-20
or LSRFortessa (BD Biosciences). Analysis was performed with FlowJo
software (FlowJo).
Western blot
Plasma was separated from EDTAwhole blood by centrifugation at 2000 G
for 15 min at 4˚C. A 1:50 dilution was prepared using SDS-PAGE loading
buffer. Proteins were separated by SDS-PAGE and transferred to nitro-
cellulose membranes for immunoblotting. Membranes were probed with
polyclonal primary Abs: rabbit anti-CSF1 (1:500, MBS551037; MyBio-
Source) and 1:2000 sheep anti-Transferrin (1:2000, ab9033; Abcam) in
PBS/3% milk powder/0.1% (v/v) Tween 20 at 4˚C overnight. The sec-
ondary Abs used were goat anti-rabbit HRP (1:5000, no. 7074; Cell Sig-
naling Technologies) and rabbit anti-sheep HRP (1:10,000, ab97130;
Abcam). Blots were visualized using Pierce ECLWestern blotting solution
(Thermo Fisher Scientific).
Histology and immunohistochemistry
Formalin fixed organs were processed into paraffin using standard proce-
dures. For histological examination, sections were stained with H&E or
Luxol fast blue. For immunohistochemical analysis, details of Ag retrieval,
Ab concentrations, and detection systems used are listed in Table II. Fe-
murs were decalcified in EDTA, and sections were stained using an acid
phosphatase and tartrate-resistant acid phosphatase (TRAP) kit (Sigma-
Aldrich) according to instructions, except incubation time was increased
to 2 h, and a counterstain was not used. Epidermal sheets were obtained
after incubating the dorsal face of both ears in 20 mM EDTA for 2 h (37˚C),
followed by fixation in 4% PFA for 20 min and washing in PBS. Tissues
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were blocked for 1 h (room temperature [RT]) in PBS/0.1% BSA/5%
goat serum, then stained with anti-rat MHC class II (MHC-II) (clone
OX-6, 1:100; Abcam). Secondary Ab was F(ab9)2-Goat anti-Mouse IgG
(H+L)AF647 (1:500, A-21053; Invitrogen). Epidermal sheets were washed
in HBSS (Thermo Fisher Scientific), and nuclei were stained for 5 min
(RT) with Hoechst 33258 (1:1000, 861405; Sigma-Aldrich). Stained epi-
dermal sheets were mounted with ProLong Gold (Life Technologies) and
cured for 24 h (RT) before imaging.
Microarrays
Total RNA was prepared from snap frozen brain regions (hippocampus,
striatum, olfactory bulbs, and pituitary gland) and spleens as described
above from nonperfused rats (two female rats per genotype). Library
preparation and hybridization to the Affymetrix Rat Gene 2.1 ST array was
performed by Edinburgh Genomics, The University of Edinburgh. CEL files
were normalized [RMA (23)] and annotated in R/Bioconductor. The data
from the microarrays are available at Gene Expression Omnibus, National
Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/geo/),
under accession number GSE100696. To identify spleen-specific genes
downregulated by the loss of Csf1r, the normalized transcriptomic data
were loaded into Graphia Pro (Kajeka, U.K.). Using a Pearson correlation
threshold cutoff of R = 0.98, a graph was obtained comprising 20,515
nodes (individual probe sets). Clustering of the graph using the Markov
clustering algorithm (MCL) was used with an MCL inflation value of 1.5
to determine the granularity of clusters.
Evaluation of blood–brain barrier permeability
A 2% solution of Evans blue in PBS (4 ml/g body weight) was injected i.p.
in postnatal day 17 rats. The stain was allowed to circulate for 3 h before
rats were culled by cervical dislocation. Spleens and brains were removed,
then weighed. The organs were dried overnight in a 55˚C oven, and Evans
blue was extracted by addition of formamide (16 ml/mg spleen and 8 ml/mg
brain). After 48 h at 55˚C, Evans blue stain was measured by spectro-
photometer at 620 nm and quantified according to a standard curve. The
results are presented as microgram of Evans blue per milligram of dried
tissue.
Statistical analysis
Analysis was performed with GraphPad Prism version 6.04, and statistical
significance was assessed using Student two-tailed t test. Resulting values
were considered statistically significant at p , 0.05.
Results
Generation and gross phenotype of Csf1r2/2 rats
Csf1r2/2 rats were produced using ESC in which the first coding
exon of rat Csf1r was disrupted with a drug selection cassette by
homologous recombination (Supplemental Fig. 1A). qRT-PCR
demonstrated partial (∼50%) and complete loss of Csf1r mRNA
in spleens from Csf1r+/2 and Csf1r2/2 rats, respectively (Fig. 1A),
indicating that there was no dosage compensation in the hetero-
zygote. The loss of functional CSF1R was demonstrated using a
labeled CSF1R ligand [porcine CSF1-Fc (6)]. There was reduced
(.60%) binding activity on monocytes (SIRPa+, SSClo cells)
from Csf1r+/2 heterozygous rats. There was no CSF1 binding
activity on any blood cells from Csf1r2/2 rats (Fig. 1B, 1C). The
loss of CSF1R activity was associated with an increase in the li-
gand in the circulation, as observed in Csf1r2/2 mice (9), con-
firmed by Western blot analysis (Fig. 1D). By contrast, Csf1r2/2
rats displayed a significant reduction in Csf1 mRNA in the spleen
(Fig. 1E). This likely reflects the depletion of CSF1-dependent
macrophages, which in rats (unlike mice, see data on www.
biogps.org or www.immgen.org) express abundant Csf1 mRNA
(see below).
Csf1r2/2 rats were indistinguishable from their littermates at
birth but were identified from P9–11 by the absence of tooth
eruption, smaller body size, and shorter snout (Fig. 2A), similar to
the reported phenotype of the Csf1 mutant (tl/tl) rat (24). The
frequencies of wild type, heterozygous, and homozygous geno-
types at birth were 27, 52, and 21% (n = 266), respectively, not
significantly different from the expected 1:2:1 ratio expected
under Mendelian inheritance (p = 0.3). All female Csf1r2/2 rats
survived beyond weaning (n = 22), but 23% of male Csf1r2/2 rats
were lost postnatally (n = 8) without obvious clinical signs.
Csf1r2/2 rats weighed less than their littermates at weaning, and
their body weight plateaued after 10 wk. As in Csf1r2/2 mice, the
differential increase in growth/body size normally seen in wild
type males was abolished in the Csf1r2/2 mutant animals, most
likely reflecting a lack of testosterone production (9) (Fig. 2B).
Tl/tl rats lack circulating insulin-like growth factor 1 (IGF1; re-
sponsible for body growth) in the postnatal period, implying a link
between CSF1R and growth hormone receptor (GHR) signaling
(25). Mouse macrophages grown in CSF1 express high levels of
Igf1 mRNA and are likely to be the major extrahepatic source
(25). We have confirmed this finding in rats (see below). In the
Csf1r2/2 rats, the mutation also impacted upon the major source
of Igf1 in the postpubertal growth surge. Both Ghr and total Igf1
mRNA levels were consistently reduced by around 50% in the
liver of mutant rats compared with age- and sex-matched litter
mate controls (Fig. 2C).
Csf1r2/2 rats were osteopetrotic, with reduced bone marrow
(BM) cavities and disrupted growth plates in the tibia (Fig. 2D).
Although Csf1r2/2 rats lack any visibly erupted teeth, mCT
analysis of the skull clearly showed molars and rudimentary in-
cisors as well as a domed skull (Fig. 2E). By 6 mo of age, a severe
curvature of the spine was apparent (Fig. 2F). Ageing Csf1r2/2
rats developed further phenotypes, including bulging eyes
Table I. Oligonucleotides
Gene Forward Oligonucleotide Reverse Oligonucleotide
Adgre4 59-TGCCCTTATTGTTGCTGTGTCTGC-39 59-CACTGGCCCCAAGAAGCTCCA-39
Cd209b 59-TCCAAGATCCCCAGCCTCCAG-39 59-GCAGAGTCGACACAGGCGGA-39
Csf1r (genotyping) 59-GCTGCAGTCCCTTACATAGGTCTAC-39 R1, 59-GGAGGTGCAGATGAACTTCAGG-39
R2, 59-AGCTTCCCCTGCCCTGAGAAG-39
Csf1 59-AGTCTTGCTGGCTGTCGGGG-39 59-GGTCGCCCCACAGAAGAATCCA-39
Csf1r 59-ACGGCCACCATGAACTTCCA-39 59-CGCAGGGTGAGCTCAAAGGT-39
Fmod 59-CCCTCCCGTCAACACCAACCT-39 59-AAGTTCATGACGTCCACCACCG-39
Gal3st2 59-GCTGGCTGTGCTCCTGTTGG-39 59-GCGGTTCCTGGGCCTTGTCC-39
Gapdh 59-ATGACTCTACCCACGGCAAG-39 59-TGGGTTTCCCGTTGATGACC-39
Ghr 59-CGGGTGTTCTTAACCCTGGCACT-39 59-GCAGAACCGGGGAAGCTTTGC-39
Total Igf1a 59-TGTGTGGACCAAGGGGCTTT-39 59-GTCTGTGGTGCCCTCCGAAT-39
Il22ra2 59-GGACACCCCGCTTCACTCCA-39 59-CCCTCAAAGATGCATTAACTCGGGT-39
Mpeg1 59-GGTTTGCCGGGTCCCTTGGT-39 59-ACATTCGTGCAGCCAGGGTG-39
Nr1h3 (Lxra) 59-GCAGAGACCCTCCCAGAGCCTA-39 59-ACACTGCATAGCTCGTTCCCCAG-39
aSpans local and circulating transcripts.
R, reverse.
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(Fig. 2G), that secreted porphyrin. The secretions were likely a
consequence of the inability to blink properly, causing corneal
dryness and increased porphyrin production. Postmortem analysis
revealed that both male and female Csf1r2/2 rats had an almost
complete absence of visceral white adipose tissue at 4.5 wk
(Fig. 2H) yet still developed interscapular brown adipose tissue
(Supplemental Fig. 2A). White adipose tissue was detected in
older Csf1r2/2 rats but was still greatly reduced when compared
with littermate controls (Fig. 2I). As the rats aged, they developed
increased respiratory rates, most likely a result of cranial bone
defects limiting the space available for soft tissues such as the soft
palate and tongue, similar to brachycephalic syndrome in certain
dog breeds (26). Indeed, the tongues of Csf1r2/2 rats were the
same size as littermate controls, despite their much smaller body
size (Supplemental Fig. 2B). A subset of males exhibited a pro-
truding penis, without any adverse effects on behavior or urina-
tion, with osteopetrosis of the penile bone being the most probable
cause.
Aside from the obvious difference in viability between mutant
rats and mice, many pleiotropic impacts of macrophage deficiency
described in Csf1 and Csf1r mutant mice (9, 27, 28) were not
observed in the Csf1r2/2 rats. For example, they showed no evi-
dence of sensory defects (sight, hearing, and smell were apparently
normal), produced insulin in histologically normal pancreatic islets
(Supplemental Fig. 2C), and retained Paneth cells in the intes-
tines, which also showed normal villous architecture (Supplemental
Fig. 2D).
Analysis of blood from Csf1r2/2 rats
Csf1r2/2 rats had a significant decrease in PBMCs, whereas the
percentages of granulocytes and erythroblasts were increased
(Fig. 3A, 3B). By contrast with the CSF1 ligand–deficient Csf1tl/tl
rat (29), there was no evidence of thrombocytopenia, nor any
change in total RBC or WBC count (Fig.4A). SIRPa+ monocytes
were unaffected in the heterozygote but were almost undetectable
in the homozygous mutant (Fig. 3C, 3D). Conversely, neutrophils
FIGURE 1. Expression of Csf1r and Csf1 in rats. (A) cDNAwas prepared from total splenic RNA and Csf1r expression analyzed by qRT-PCR (n = 7+/+,
7+/2, and 32/2). (B) Whole EDTA blood was used to analyze SIRPa expression and binding of CSF1R to its ligand (CSF1-Fc) by flow cytometry. Regions
R1–R3 highlighted in Csf1r+/+ rat blood were back-gated onto a forward versus side scatter (FSC/SSC) dot plot to highlight the three main cell populations
in blood. (C) Combined mean fluorescent intensity of CSF1-Fc binding in SIRPa+ monocytes (n = 6+/+, 8+/2, and 52/2). (D) Protein lysates were prepared
from EDTA plasma (female adults) and assessed for CSF1 expression by Western blot. An anti-transferrin (TRF) Ab was used as the loading control. (E)
cDNA was prepared from total spleen RNA and Csf1 expression analyzed by qRT-PCR (n = 7+/+, 7+/2, and 32/2). Graphs show the mean + SEM.
Significance compared with wild type is indicated by *p = 0.015 and ****p , 0.0001 using a t test.
Table II. Immunohistochemistry conditions
Target (Clone) Supplier Ag Retrieval Dilution Detection
CD68 (ED1) Bio-Rad Proteinase K 20 min, RT 1:500 ImmPRESS anti-mouse 15 min
45 min DAB, hematoxylin counterstain
CD163 (ED2) Thermo Fisher Scientific Proteinase K 20 min, RT 1:100 ImmPRESS anti-mouse 10 min
60 min DAB, hematoxylin counterstain
IBA1 rabbit polyclonal Wako Pure
Chemical Corp.
0.01 M citrate buffer, pH 6.0 1:500 EnVision anti-rabbit 40 min
110˚C 5 min 30 min DAB, hematoxylin counterstain
MRC1 rabbit polyclonal Abcam 1 mM EDTA, 0.1% Tween 20, pH 8 1:1000 EnVision anti-rabbit 40 min
16 h 60˚C 60 min Vector NovaRED, hematoxylin
counterstain
SIGLEC1 (ED3) Bio-Rad 0.01 M citrate buffer, pH 6 1:200 ImmPRESS anti-mouse 30 min
110˚C 20 min 2 h Vector VIP, no counterstain.
DAB, 3,3-diaminobenzidine.
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were increased and lymphocytes were decreased (Fig. 3E) as
reported previously in the Csf1r2/2 mice (9). There was no
change in relative abundance of B, T, or NK cells within
the lymphoid compartment (Fig. 4B, 4C). Blood albumin and
electrolyte levels were unaffected by the mutation (Fig. 4D, 4E),
with the exception of calcium and inorganic phosphate, which
were both significantly reduced, most likely associated with de-
ficient bone resorption.
Fertility of Csf1r2/2 rats
Csf1tl/tl male rats reach sexual maturity and were reported to be
fertile (17). To date, male Csf1r2/2 rats have produced no preg-
nancies when placed with wild type females. Histological analysis
revealed a severe reduction in the number of mature sperm cells in
the lumen of the epididymis and a large number of atypical re-
sidual bodies, suggesting impaired maturation of spermatids (30)
(Fig. 5A). The mAb ED1 recognizes rat CD68 and is commonly
used to identify rat macrophages (31). In the testis of Csf1r2/2
males, there was a decrease in CD68+ interstitial macrophages
(Fig. 5B), similar to that shown in mice treated with anti-CSF1R
(32). The size difference between Csf1r2/2 females and adult
male wild type rats precluded test mating on welfare grounds, but
the females are also likely to be infertile. Their ovaries were
greatly reduced in size, and corpora lutea were either absent or
greatly reduced (Fig. 5C). The few corpora lutea that were ob-
served lacked CD68+ macrophages (Fig. 5D), which are known to
regulate corpus luteum development in mice (33).
Analysis of tissue macrophages in Csf1r2/2 rats
There was a reduction of CD68+ macrophages in both the red pulp
and the periarteriolar lymphoid sheath in spleen compared with
wild type and heterozygous rats (Fig. 6A, 6B). This decrease was
partly due to extensive infiltration of the red pulp by small
mononuclear cells. There were no nucleated RBCs and no obvious
increase in the number of megakaryocytes (Fig. 6A). Hence, there
was no evidence of the extramedullary hematopoiesis that occurs
in Csf1r mutant mice in the absence of a BM cavity (9). To
evaluate the impact of the mutation on spleen cell populations, we
FIGURE 2. Gross phenotype of Csf1r2/2 rats. (A) Two Csf1r2/2 rat pups and a littermate control at postnatal day 11. (B) Rats were weighed weekly
following weaning at P21. For males, n = 5+/+, 8+/2, and 32/2. For females, n = 7+/+, 4+/2, and 82/2. Animals culled prior to 11 wk of age were included in
the analysis. Graph shows the mean + SEM. (C) Total RNAwas isolated from livers of wild type (+/+) and Csf1r2/2 rats (n = 6) for analysis of Ghr and total
Igf1 expression via qRT-PCR. There were equal numbers of males and females, four animals were adults, and two were 18 d old in each group. Graph shows
the mean + SEM for pairwise comparison with age- and sex-matched littermate controls. Absolute values did not differ markedly between males and
females or ages. Significance compared with wild type is indicated by ****p , 0.0001 using a t test. (D) Lower limbs from 7-wk males were fixed in 10%
buffered formalin and analyzed for bone density by mCT. Dotted arrow indicates growth plate. (E) Skulls from 7-wk males were scanned by mCT. (F) Rats
were analyzed by radiography at 6 mo of age. mCT images are from females, which are representative of both sexes. (G) An adult female Csf1r2/2 rat with
bulging eyes. Representative photograph of the abdominal cavities of 4.5-wk-old (H) and 11-wk-old (I) females. Arrow points to visceral fat in the wild type
(left) and absence or reduction of visceral fat in Csf1r2/2 rat (right). Images are also representative of males. B, bladder.
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compared gene expression profiles from Csf1r+/+ and Csf1r2/2
rats with BM-derived macrophages (BMDM). The full data
are provided in Supplemental Table I. The set of 543 transcripts
with expression ratios from 0.02 (Csf1r) to 0.5 (calculated as the
ratio of expression in Csf1r2/2 to expression in littermates)
(Supplemental Table I) includes CD68 (consistent with Fig. 6A),
transcription factors (SpiC, Pparg), and the majority of markers of
splenic red pulp macrophages including Adgre1 (F4/80) (Fig. 6C).
The reduction in the relative abundance of these transcripts (and
by inference, the red pulp macrophages) may be partly attributable
to the overall expansion of the lymphoid populations. The in-
creased relative expression of T cell–associated genes (Fig. 6C)
indicates that this expansion is biased toward T lymphocytes,
whereas B cell markers were all reduced (Fig. 6C). A similar bias
toward T cells was reported when Csf1 was disrupted in mice (34).
The spleen contains multiple different mononuclear phagocyte
populations occupying specific niches, including the red pulp
macrophages, marginal zone macrophages and metallophils, tin-
gible body macrophages, and classical dendritic cells (35). The
network analysis tool Graphia Pro (formerly BioLayout Express3D)
was used to identify spleen-specific, macrophage-related genes
that were downregulated with the loss of Csf1r. The Csf1r-
dependent genes identified included markers of the separate
marginal zone (Siglec1) and marginal zone metallophilic
(CD209b) macrophages (Fig. 6D). Complete loss of the former
population was confirmed via immunohistochemistry with an anti-
SIGLEC1 Ab (Fig. 6E). The selective loss of CD209b, as well
as a number of other candidate marginal zone-associated tran-
scripts discussed below, was confirmed by qRT-PCR (Fig. 6F).
The selective loss of the marginal zone macrophages may explain
the disrupted splenic architecture and the migration of lymphocytes
into the red pulp.
In the liver, CD68+ Kupffer cells were unaffected in the het-
erozygotes but partially depleted in Csf1r2/2 rats. The residual
CD68+ cells appeared smaller and less ramified, but there was
otherwise no gross change in liver size (relative to body weight) or
architecture (Fig. 7A, 7B). Liver enzymes, alanine aminotrans-
ferase, and alkaline phosphatase were marginally increased in the
circulation, but bile acids and bilirubin were unchanged and there
was no histological evidence of injury (Fig. 4D, 4E). As in the
Csf1r2/2 mice (9), peritoneal macrophages were absent in the
Csf1r2/2 rats (Fig. 7C).
To examine effects on bone architecture, femurs were stained for
TRAP (also known as ACP5) and CD68. As noted also in Fig. 2D,
despite the cortical thickening and increased trabecular bone, the
Csf1r2/2 rats retained a substantial BM compartment. This likely
explains the lack of extramedullary hematopoiesis in the spleen.
Osteoclasts were entirely deficient in Csf1r2/2 rats (Fig. 7F), as
reported in Csf1tl/tl rats (17), whereas in Csf1r2/2 mice TRAP+
cells are retained, albeit at a lower frequency (9). The surface of
bone in mice and humans contains a population of specialized
osteal macrophages, intercalated among the osteoblasts (36).
Abundant osteal macrophages were detected with CD68 staining
in rat bone, and they were completely absent in bones from the
Csf1r2/2 animals (Fig. 7G).
In mice, IL-34 is also expressed in the epidermis and is required
for the development of the MHC-II–positive epidermal Langer-
hans cells (37). In the Csf1r2/2 rats. MHC-II+ Langerhans cells,
FIGURE 3. Analysis of whole blood. (A) Whole EDTA blood from adult rats was used to analyze forward versus side scatter (FSC/SSC) profiles by flow
cytometry. SIRPa+ monocytes are colored red. (B) The percentages of PBMCs, granulocytes, and erythroblasts were determined by FSC/SSC profiles (n = 5
per genotype). (C) Cells were gated on SIRPa+ PBMC to determine the percentage of monocytes (n = 5 per genotype). (D) SIRPa expression was analyzed
in whole EDTA blood gating on total live cells and live PBMC. Solid arrow highlights SIRPalow granulocytes. Dotted arrow highlights SIRPahigh
monocytes (n = 5 per genotype). (E) Whole EDTA blood was analyzed on an automated counter to determine the percentage of neutrophils and lym-
phocytes in WBCs (n = 6+/+, 10+/2, and 82/2). Graphs show the mean + SEM. Significance compared with wild type is indicated by *p = 0.046
(erythroblasts) and 0.015 (monocytes), ***p , 0.0003, and ****p , 0.0001 using a t test.
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visualized in epidermal sheets, were almost completely depleted
(Fig. 7H, 7I); the few remaining cells were only weakly MHC-II+.
Dermal macrophages were also absent in Csf1r2/2 rats as detected
by CD206 (mannose receptor, MRC1) expression (Fig. 7J).
Analysis of Csf1r2/2 rat brains
The brains of Csf1r2/2 rats at 11 wk of age revealed few ab-
normalities apart from some enlargement of the lateral ventri-
cles (Fig. 8A). Whereas Csf1r2/2 mice had hollow and fragile
olfactory bulbs (27), these were intact and apparently normal in
the rat (Fig. 8B). Minor loss of myelin was apparent at the level
of the corpus callosum (Fig. 8C). Csf1r-deficient mice had a
gross deficiency of microglia, detected with the microglial
marker, IBA1 (27). IBA1+ cells with ramified morphology were
similarly not detectable in any region of the brain (Fig. 8D) or
in the plexiform layers of the retina (Fig. 8F, 8G) in adult
Csf1r2/2 rats. To confirm that this deficit was due to a loss of
microglia, rather than loss of the marker, cells extracted from
total brain tissue were analyzed (21). CD11b/c+CD45low
microglia were entirely absent in Csf1r2/2 rats (Fig. 9A), and
CD11b/c+CD45hi macrophages (normally a minor component in
brain digests) were decreased. The population of CD11b/c2CD45hi
cells was increased in Csf1r2/2 rats. We attribute this to blood
contamination as a result of incomplete perfusion (discussed
below).
The brain, like the spleen, contains several macrophage
populations in addition to microglia (38). To further analyze the
impact of Csf1r mutation on brain myeloid populations and on
other brain cells, we profiled gene expression in the striatum,
hippocampus, olfactory bulbs, and pituitary gland. The full
dataset is provided in Supplemental Table I. There was no
global change in expression of generic neuron-associated genes
in Csf1r2/2 rats shared by the four brain regions examined, but
there was some evidence of region-specific impacts, discussed
below.
The set of 131 transcripts with expression ratios from 0.03 (Ctss,
Cx3cr1, and Csf1r) to 0.5 (Supplemental Table I) contains many
microglia-enriched transcripts identified in mice (Fig. 9B) (39–41)
and rats (42). By contrast to the loss of microglia-specific markers,
many macrophage-associated marker genes remained readily de-
tectable in Csf1r2/2 brains (e.g., Cd14 and Fcgr1a encoding CD64).
We attempted to locate residual macrophages with known mark-
ers. As in the Csf1r-deficient mouse (27), there were no detectable
CD68+ cells in Csf1r2/2 rat brains via immunohistochemistry
(data not shown). Csf1r2/2 rats retained IBA1+ macrophages in
the choroid plexus (Fig. 9C) but lacked detectable CD163+ peri-
vascular macrophages (43) and MRC1+ meningeal macrophages
(38) (Fig. 9D, 9E).
The blood–brain barrier was intact in Csf1r2/2 rats, as evident
from Evans blue exclusion. Interestingly, there was an obvious
FIGURE 4. Further analysis of Csf1r-deficient rat blood. (A) Whole EDTA blood was used to determine the total number of WBCs, RBCs, and platelets
from male and female rats aged between 6 and 12 wk (n = 6+/+, 11+/2, and 82/2). (B) Whole EDTA blood was analyzed by flow cytometry to identify B, T,
and NK cells. Dot plots show gating strategy for each cell type using Csf1r +/+ blood. Cells were gated on the PBMC population by forward versus side
scatter (FSC/SSC). Quadrants were determined with isotype controls (n = 5+/+ and 62/2). (C) Graphs shows the mean + SEM. p = 0.09, 0.23, and 0.63 for B,
T, and NK cells, respectively. (D and E) Serum from male and female rats aged 2–4 wk was analyzed (n = 5 per genotype). Graphs shows the mean + SEM.
**p = 0.0018, ***p = 0.0010 (inorganic phosphate) and 0.0007 (ALT). ALT, alanine aminotransferase; AP, alkaline phosphatase, K+, potassium.
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reduction in Evans blue staining in the periphery of Csf1r2/2 rats,
suggesting a subtle vascular phenotype. Evans blue staining in
the spleen was also reduced (Fig. 9A), despite no differences in
levels of the carrier albumin (Fig. 4E), potentially highlighting the
known role of macrophages in angiogenesis (reviewed in Ref. 44).
Network analysis of gene expression in the spleen of
Csf1r-deficient rats
In previous studies of the effect of CSF1 treatment on macrophage
numbers and gene expression profiles in the liver, BMDM were
used as an external reference to identify genes that were enriched in
macrophages relative to the tissue (45). These genes provided a
signature of CSF1-dependent expansion of the macrophage pop-
ulation detectable in total mRNA from the liver (45). To provide a
similar reference for the rat, BMDM were generated by cultivation
in a medium containing recombinant human CSF1 for a period of
7 d as described for mouse (45), mRNA was isolated, and tran-
script expression was profiled in parallel with tissue mRNA from
adult rats.
To identify the set of genes that were spleen enriched, based upon
comparison with BMDM grown in CSF1, the wild type, hetero-
zygous, and homozygous Csf1r mutant expression profiles were
combined with BMDM and clustered using Graphia Pro. Sur-
prisingly, one of the two heterozygous mutant animals had much
lower expression of Csf1r, albeit higher than in the knockout.
(Supplemental Table I).
The network graph divided into two major aggregates, essentially
comprising clusters of macrophage-enriched and spleen-enriched
FIGURE 5. Histology of reproductive or-
gans. Formalin-fixed and paraffin-embedded
epididymides, testes, and ovaries were stained
with H&E or an Ab against CD68. (A) Longi-
tudinal sections of epididymides and (B) testes.
Images are representative of six rats aged be-
tween 7 and 11 wk. Arrows point to atypical
residual bodies. Scale bar, 250 mm. (C and D)
Longitudinal sections of ovaries stained with
H&E and CD68. Images are representative of
seven rats aged 11–12 wk. Scale bar, 1.5 mm
(C) and 250 mm (D). In wild type and Csf1r+/2
rats, an average of 5.8 (range 3–11) corpora
lutea were observed per ovary in H&E-stained
sections (n = 10) compared with only 0.7
(range 0–3) in Csf1r2/2 rats (n = 7). Whole
slide images were produced with a Nano-
Zoomer slide scanner and images were expor-
ted with NDP.view2 software (Hamamatsu
Photonics). CL, corpus luteum, S, sperm.
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transcripts. Fig. 10A shows the clustered nodes for the main ele-
ment in the layout graph.
Five clusters of specific interest are among those listed in
Supplemental Table I, together with their average expression
profile. The largest cluster, cluster 1 (2171 genes; green nodes),
was strongly enriched in the spleen compared with BMDM and
not sensitive to Csf1r mutation. The second largest cluster
(cluster 2, 1986 genes; purple nodes) was strongly enriched
in the BMDM and also was not affected by the loss of Csf1r.
This list is a complex mixture of genes associated with
phagocyte biology and include Adgre1 (F4/80), Itgam (CD11b),
components of the vacuolar ATPase (Atp6v family), Fcgr, and
Clec families. The existence of this cluster indicates that there
is a substantial residual macrophage population in the spleen
of Csf1r2/2 rats, and they share with BMDM the majority of the
generic macrophage transcriptome. That conclusion is consis-
tent with the residual CD68 staining in Fig. 6A and 6B. Also
within cluster 2, there were more general anabolic/metabolism-
associated genes involved in mitochondria (e.g., Nduf, Cox,
Mrpl families) and RNA/protein synthesis. The enrichment
of these genes in cluster 2 reflects the difference between a
pure growing macrophage population and the splenic lymphoid
population, in which most of the cells are relatively metaboli-
cally inactive.
Csf1r-dependent clusters varied in their level of spleen en-
richment. The expression profile of cluster 6 (238 genes) was
much higher in spleen than in BMDM and downregulated in the
knockout and in the low Csf1r-expressing heterozygote. Cluster
30 (24 genes) had a similar expression profile to cluster 6, but with
higher relative expression in BMDM. The spleen-specific cluster
6 contained the signature gene for the marginal zone macrophages
(Siglec1) which was among the most downregulated with the loss
of Csf1r (Supplemental Table I). The IL-22–binding protein,
encoded by Il22ra2, has recently been studied in detail in Peyer
FIGURE 6. Analysis of spleens in Csf1r2/2 rats. (A) Formalin-fixed and paraffin-embedded spleens were stained with an Ab against CD68. Scale bar,
500 mm. Inset shows an area of red pulp. Scale bar, 50 mm. Arrow points to infiltration of lymphocytes in Csf1r2/2 inset. Whole slide images were
produced with a NanoZoomer slide scanner and jpeg files exported with NDP.view2 software. PAL, periarteriolar lymphoid sheath. (B) The area of CD68+
cells in the red pulp was determined from 10 images per spleen (at original magnification 380) using ImageJ (Fiji) (n = 10+/+, 8+/2, and 132/2). Graph
shows mean + SEM. Significance compared with wild type is indicated by ***p = 0.0002 using a t test. (C) Microarray data from spleens were used to
determine expression ratios for genes associated with red pulp macrophages and T and B cells. Graph shows mean + SEM for genes with multiple probes.
(D) Gene expression plot generated in Graphia Pro highlighting splenic macrophage-specific genes which were downregulated in Csf1r2/2 rats. (E)
Formalin-fixed and paraffin-embedded adult spleens were stained with an Ab against SIGLEC1. Scale bar, 100 mm. Images are representative of 2+/+ and
32/2 rats and two repeat experiments. (F) Total RNAwas isolated from spleens of adult wild type (+/+) and Csf1r2/2 rats (n = 3) for analysis of candidate
marginal zone macrophage-associated gene expression identified in (D) via quantitative PCR. Graph shows mean + SEM. Significance compared with wild
type is indicated by ***p = 0.003 and ****p , 0.0001 using a t test.
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patch, where it is highly expressed by myeloid cells underlying
follicle-associated epithelium, regulates IL-22 signaling, and in-
directly affects bacterial uptake (46). The loss of this transcript
was confirmed by qRT-PCR (Fig. 6F).
The gene expression profile in the spleen of Csf1r-deficient
rats is consistent with almost complete loss of the marginal zone
macrophage populations. These cells, and the related Ag cap-
ture cells in the subcapsular sinus of lymph nodes, were also
depleted in op/op mice (47). The data suggest that relatively few
Csf1r-dependent genes are absolutely restricted to the marginal
zone.
Genes that are less spleen specific but are nevertheless Csf1r
dependent (e.g., those in cluster 13, including Sirpa) may be
shared by macrophages of the marginal zone and red pulp, or
specifically associated with red pulp macrophages. Overall, the
main impact of Csf1r-deletion is to compromise spleen-specific
macrophage differentiation.
Network analysis of gene expression in the brain of
Csf1r-deficient rats
As with the spleen, the first pass analysis of gene expression
data for two brain regions was to determine the expression ratios
(ratio of Csf1r2/2/littermates) for each of the transcripts on the
arrays in each of the tissues. There was no global change in ex-
pression of generic neuron-associated genes in Csf1r2/2 rats
shared by the brain regions examined, but there was some evi-
dence of region-specific impacts (Supplemental Table I). There
were several overlaps between the Csf1r-dependent genes in the
brain regions and spleen, including Gpr31, Gpr34, Cd33,
Tmem119, Tmem176a, P2ry13, Pld4, Clec4a1, and C1q genes, but
FIGURE 7. Analysis of tissue macrophages in Csf1r-deficient rats. (A) Formalin-fixed and paraffin-embedded livers were stained with an Ab against
CD68. Whole slide images were produced with a NanoZoomer slide scanner and exported as jpeg files with NDP.view2 software. Scale bar, 100 mm. (B)
The area of CD68+ cells was determined from 10 images per liver (at original magnification 320) using ImageJ (n = 7+/+, 4+/2, and 92/2). Graph shows
mean + SEM. Significance compared with wild type is indicated by **p = 0.0035 using a t test. (C) Peritoneal cavity cells were analyzed by flow cytometry
for expression of SIRPa and CD11b/c. Dead cells were excluded with propidium iodide, and quadrants were set with isotype controls. (D) Graph shows
mean + SEM of CD11b/c+SIRPa+ peritoneal macrophages. Significance compared with wild type/heterozygotes is indicated by ****p , 0.0001 using a
t test (n = 3). Decalcified femurs from adult rats were either stained with (E) H&E or stained for expression of (F) TRAP and (G) CD68. The boxed
growth plate in (E) shows the area of TRAP staining. Images are representative of five rats per genotype. Scale bar, 200 mm (H&E), 500 mm (CD68), or
50 mm (TRAP). Whole slide images were produced with a NanoZoomer slide scanner and images exported with NDP.view2 software. (H) Epidermal
sheets were prepared from the ears of adult rats and immunostained for MHC-II (red). Nuclear staining was performed using Hoechst 33258 (blue).
Epidermal sheets were imaged as z-stacks (25 mm) using a Zeiss LSM710 confocal microscope. MHC-II and nuclei signals were acquired with 633 and
405 nm lasers, respectively. (I) Maximum intensity projections were produced from the z-stacks and MHC-II+ cells were quantified as per (102). Graph
shows mean +SEM. Significance compared with wild type/heterozygotes is indicated by ****p , 0.0001 using a t test. Images are representative of
four rats per genotype, two z-stacks analyzed per rat. Scale bar, 50 mm. (J) Formalin-fixed and paraffin-embedded dorsal skin was immunostained for
MRC1 expression. Image is representative of 2+/+ and 32/2 adult rats per genotype and two repeat experiments. Arrows point to MRC1+ dermal
macrophages. Whole slide images were produced with a NanoZoomer slide scanner and images exported with NDP.view2 software. Scale bar, 50 mm.
E, epidermis.
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most were not shared, consistent with the tissue-specific adapta-
tion of Csf1r-dependent macrophages in the two locations. Fig.
10B shows the network graph for the combined analysis of the
four brain regions; gene lists are provided in Supplemental
Table I. The largest cluster was cluster 1 (4283 genes), contain-
ing olfactory bulb–associated genes. Other region-specific clusters
were cluster 3 (pituitary gland; 878 genes), cluster 5 (hippocam-
pus; 513 genes), and cluster 7 (striatum; 384 genes). The second
largest cluster (cluster 2; 1253 genes) contained genes that were
more highly expressed in both hippocampus and striatum. Two
other main clusters also shared highly expressed genes between
tissues: cluster 4 (pituitary gland, striatum and hippocampus; 757
genes) and cluster 6 (pituitary gland and olfactory bulb; 471
genes). None of these clusters showed any evidence of genotype
association. Cluster 10 (107 genes) contained genes that were
downregulated in the Csf1r2/2 rats in all brain regions, including
Csf1r itself (Fig. 10B). This set contains most known microglia-
specific transcripts and is presumably attributed to the loss of
microglia.
Discussion
The Csf1r knockout rats described in this article join a small set of
rat knockout lines that have been produced via homologous re-
combination in ESC [(48) and reviewed in Ref. 13]. The com-
parison between rat and mouse mutant phenotypes supports the
view that the rat, in many cases, provides a superior model for
studying human genetic disease. For example, p53–deficient rats
exhibited a more human-like tumor spectrum than mice (49), and
dystrophin mutant rats displayed heart defects which were more
similar to the human condition Duchenne muscular dystrophy
(50, 51). The phenotype of Csf1r2/2 rats is clearly very different
from mice, and because of the improved viability, we have
assayed phenotypes that could not be accessed in mice. In any
insertional mutagenesis, or deletion, there is always the possibility
of cis-acting impacts on neighboring genes. The two genes
neighboring Csf1r, namely Hmgxb3 and Pdgrb, are both robustly
expressed in all three tissues examined by gene expression pro-
filing, and there was no significant change in their expression in
response to insertional mutagenesis of Csf1r.
A common trait between Csf1r2/2 rats and mice is increased
bone density (osteopetrosis) attributed to either a reduction (mice)
or complete absence (rats) of bone-resorbing osteoclasts. In hu-
mans, genetic susceptibility to disordered bone turnover in Paget
disease has been linked to variation at the Csf1 locus (52). In
Csf1tl/tl rats, there is a severe loss of osteoclasts in addition to the
loss of osteoblasts (53). Unlike Csf1tl/tl rats (54), the Csf1r2/2 rats
developed a BM cavity, albeit reduced, and showed no evidence of
extramedullary hematopoiesis in the spleen. Nevertheless, only
monocytes were greatly reduced in the blood. We speculate that
the loss of macrophages in liver and spleen increases the half-life
of red cells, platelets, and neutrophils, compensating for reduced
production by the BM. The receptor mutants also do not display
the early onset deafness seen in Csf1tl/tl rats, attributed to auditory
ossicle abnormalities (55). The loss of osteoclasts in Csf1r2/2 rats
is probably balanced in part by deficient calcification by osteo-
blasts. Osteoblasts on the bone surface interact intimately with a
population of osteal macrophages, which are essential for intra-
membranous and endochondral ossification (36, 56). In the
Csf1r2/2 rat, there were no CD68+ osteal macrophages detectable
on the bone surfaces (Fig. 7F). The difference between ligand
FIGURE 8. Analysis of brains from Csf1r2/2 rats. All brains were formalin fixed and paraffin embedded for histology and immunohistochemistry. (A)
Brains from 11-wk-old rats were stained with H&E. Images are representative of seven rats per genotype. Scale bar, 5 mm. (B) Adult heads were fixed in
formalin and stained with H&E following EDTA decalcification. Image shows olfactory bulbs in situ. Scale bar, 1 mm. Image representative of seven rats
per genotype. EPL, external plexiform layer; GL, glomerular layer; IGC, internal granular cell layer of the olfactory bulbs; MCL, mitral cell layer. (C)
Formalin-fixed brains from 3-wk-old rats were stained with Luxol fast blue. Arrows point to myelin preservation and myelin pallor in wild type and mutant
rats, respectively. Image of three rats per genotype. (D) Adult brains (8–14 wk) were stained with an Ab against IBA1. Scale bar, 1 mm (left) or 100 mm
(right). (E) For each rat, 10 203 images of the cortex were analyzed for the percentage of IBA1+ staining using ImageJ (n = 7 per genotype). Graphs show
mean + SEM. Significance compared with wild type is indicated by ****p , 0.0001 using a t test. (F and G) Formalin-fixed eyes were stained with an Ab
against IBA1. Arrows point to IBA1+ microglia in the inner plexiform layer of the retina. Images are representative of two rats per genotype, two repeat
experiments. Scale bar, 250 mm (F) and 50 mm (G).
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and receptor mutations presumably reflects the role of the second
ligand, IL-34. Both CSF1 and IL-34 (57) are produced by osteo-
blasts and contribute to osteoclastogenesis. It appears likely
that IL-34 is essential for rat osteal macrophage development.
Conversely, there is a lack of sperm development and fertility in
male Csf1r2/2 rats, whereas Csf1tl/tl male animals are fertile. This
suggests that the alternative ligand, IL-34, has a specific function
in testis development in the rat. Consistent with that hypothesis,
Il34 mRNA is highly expressed in rat testis and downregulated
by candidate male contraceptives (58).
Other phenotypes shared between Csf1r2/2 rats and mice in-
clude postnatal growth retardation, lack of tooth eruption, reduced
circulating monocyte numbers, defects in fertility, reduction in
liver and peritoneal macrophages, and loss of Langerhans cells.
The most obvious difference between Csf1r2/2 rats and mice is
the greatly increased viability, relative lack of a severe brain
phenotype, and absence of effects on the sensory nervous system,
insulin/pancreatic islet development, and gastrointestinal tract
in the rats, as noted above. These species-specific differences,
especially the latter two, probably contribute to the improved
postweaning survival of the rat knockout compared with the
mouse. The gut phenotype in mice has been attributed to Csf1r
expression by Paneth cells, which appeared to be absent in mutant
mice, and Csf1 signaling is proposed to indirectly control the
differentiation of intestinal epithelial cells (59, 60). Treatment of
mice with anti-CSF1R Ab completely depleted intestinal macro-
phage populations and lysozyme expression in the intestinal crypts
and was associated with an increase in goblet cells (32). More
recently, we demonstrated that Csf1r mRNA is not expressed in
mouse Paneth cells, but macrophages intimately associated with
the crypt control the differentiation of these cells and Lgr5+ stem
cells. Whereas lysozyme expression was Csf1r dependent, other
Paneth cell markers, including defensins, were not. In addition to
increased goblet cell formation, anti-CSF1R treatment produced a
complete loss of Ag-sampling M cells (61). In the rat Csf1r
knockout, there was no effect on the cellularity of the lamina
propria, no loss of Paneth cells, no increase in goblet cells, and no
discernible change in villus architecture (Supplemental Fig. 2). In
mice, the large intestinal macrophage population apparently de-
pends upon continuous replenishment from circulating monocytes
(62). In the Csf1r mutant rat, monocytes were greatly reduced, yet
there was no apparent impact on the intestine.
In contrast, the almost complete loss of visceral fat in Csf1r2/2
rats at an early age is a novel phenotype that has not previously
been noted in mice. The Csf1op/op mouse is not deficient in adipose
tissue but does have a reduction of macrophages in this tissue (63).
Adipose tissue growth is related to growth hormone and IGF1
production (64). Hence, the loss of adipose tissue is most likely
linked to the reduced GHR and IGF1 we observed in the liver and
the consequent loss of circulating IGF1, as noted previously in
Csf1tl/tl rats (45). A previous study also noted the loss of GHR
expression in the bone of Csf1tl/tl rats (65).
Injection of Evans blue stain highlighted a deficiency in de-
velopment of the peripheral vasculature in Csf1r2/2 rats. Notably,
FIGURE 9. Further analysis of brains from Csf1r2/2 rats. (A) Single-cell suspensions of brain were depleted of myelin and analyzed by flow cytometry
for CD11b/c and CD45 expression. Dead cells were excluded with propidium iodide, and blood granulocytes were excluded from Csf1r2/2 samples via
forward versus side scatter (FSC/SSC). Quadrants were determined using isotype controls. Image is representative of six rats per genotype. (B) Microarray
data from dissected striatum, hippocampus, olfactory bulbs, and pituitary gland were used to determine expression ratios for genes associated with the
major cell populations of the brain. (C) Choroid plexuses from adult brains stained with an Ab against IBA1. Images are representative of seven rats per
genotype. Arrows point to IBA1+ choroid plexus macrophages. Sclae bar, 50 mm (D) Adult brains were stained with an Ab against CD163. Images are
representative of seven rats per genotype. Solid arrows point to CD163+ perivascular macrophages. Dotted arrows point to blood vessels. Scale bar, 50 mm.
(E) Adult brains were stained with an Ab against MRC1. Images are representative of seven rats per genotype. Solid arrows point to MRC1+ meningeal
macrophages in the Csf1r+/+ rat brain. Red arrow points to a monocyte in the Csf1r2/2 meninges (M). Scale bar, 50 mm. Whole slide images were produced
with a NanoZoomer slide scanner and analyzed with NDP.view2 software (Hamamatsu Photonics).
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FIGURE 10. Network analysis of gene expression in the spleen and brains of Csf1r deficient rats. RMA-normalized microarray data from Supplemental
Table I was analyzed with Graphia Pro. Edges have been removed for ease of visualization. Nodes allocated to the same cluster are the same color.
Histograms show the averaged expression patterns of all genes in the cluster. Boxed clusters refer to genes affected by loss of Csf1r. Unboxed clusters refer
to genes that are tissue specific (*). (A) Key clusters from spleen. All known genes in which no sample reached an intensity of 20 were excluded. Analysis
was performed at a Pearson correlation coefficient $0.95 (12,305 nodes making 1,746,925 edges). Clustering was performed at an inflation of 2.0 with a
minimum cluster size of 10. (B) Key clusters from brain. All known genes in which no sample reached an intensity of 20 were excluded. Analysis was
performed at a Pearson correlation coefficient $0.85 (11,833 nodes making 3,617,804 edges). Clustering was performed at an inflation of 2.0 with a
minimum cluster size of 10. Three clusters (circled numbers) shared gene expression with multiple brain regions: cluster 2 (striatum and hippocampus),
cluster 4 (pituitary gland, striatum, and hippocampus), and cluster 6 (olfactory bulb and pituitary gland). Histograms for these clusters are shown in
Supplemental Table I.
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the apparent leakiness in the spleen (Supplemental Fig. 3B) ap-
pears to be associated with the marginal zone and may be an in-
direct consequence of the loss of the marginal zone macrophages.
The tl/tl CSF1 mutant rats display impaired capillary proliferation
in the femur, which can be rescued with CSF1 treatment (66).
However, the peripheral blood vessels have not been examined in
these rats.
The gene expression analysis in Fig. 6C and 6D allowed us to
identify spleen-specific genes that were downregulated with the
loss of Csf1r. The large majority of genes enriched in BMDM
relative to spleen were not affected. Transcripts associated
with classical dendritic cell differentiation, such as Itgax, Zbtb46,
Ly75, or Clec9a, were also unaffected, suggesting that these cells
are not Csf1r dependent. Those genes that were both spleen
enriched and Csf1r dependent provide a surrogate indicator of
the loss of specific cell populations. The marginal zone macro-
phages of the mouse have resisted isolation and characterization
(41). The commonly studied marker genes Siglec1 (marginal zone
macrophages) and CD209b (marginal metallophils) (35) were al-
most ablated in Csf1r2/2 rats, and coregulated genes are impli-
cated, by association, in marginal zone macrophage differentiation
and function (Supplemental Table I). Very few genes show the
same level of Csf1r dependence. One example is the IL-22–
binding protein, encoded by Il22ra2. This transcript is highly
expressed by myeloid cells underlying mouse follicle-associated
epithelium, regulates IL-22 signaling, and indirectly affects bac-
terial uptake (46).
The marginal zone macrophage population is also absent from
Csf1op/op mice (47). Marginal zone macrophages in mice are
distinguished from red pulp macrophages by expression of the
widely used macrophage marker, F4/80, encoded by Adgre1
(previously Emr1) (67). Adgre1 is also highly expressed by rat
macrophages (Supplemental Table I), and the relative loss of ex-
pression in the knockout spleen (∼70%) is consistent with
expression in the red pulp macrophages. The related gene, Adgre4
(previously Emr4), was strongly spleen enriched and highly Csf1r
dependent (Fig. 6F). ADGRE4 was shown to mediate binding to
B lymphocytes (68), supporting the hypothesis that it may be a
novel functional marginal zone marker.
The set of candidate marginal zone–enriched transcripts in-
cludes the transcription factor Nr1h3 (aka Lxra) (Fig. 6F), which
is essential for both marginal zone macrophage populations in
mouse (69). Other transcription factors coregulated with Lxra
(Supplemental Table I, cluster 6) included Nfe2, Nr1d1, Rara,
Klf2, and Tcf21.
One report on Nr1d1 in macrophages confirms the enriched
expression in mouse splenic macrophages and a circadian oscil-
lation (70). Regulated expression of the retinoic acid receptor,
Rara, has also been associated with myeloid differentiation (71),
and treatment of mice with retinoids led to an expansion of the
marginal zone in spleen (72). Tcf21 is required during develop-
ment for the formation of a spleen (73). This Csf1r-dependent
cluster also contained multiple growth factors of the TGFB
(Tgfb2, Tgfb3) and BMP (Bmp2, 3, 4, 6) families, which could
contribute to the differentiated phenotype of splenic macrophages
(74, 75). Expression of the transcription factors Tfec and Tcf7l2
was downregulated with the loss of Csf1r (Supplemental Table I).
Tfec is a member of the MITF transcription factor family and is
known to be macrophage enriched and PU.1 dependent (76).
Analysis of the Tfec2/2 mouse suggested a role in IL-4–inducible
expression of genes, including Csf3r (77), which was also
downregulated in the Csf1r2/2 spleen. Our finding suggests that
Tfec could have a specific function in splenic macrophages. Tcf7l2
is associated with differentiation of plasmacytoid dendritic cells
(78). Plasmacytoid dendritic cells express Csf1r and were found to
be 70% reduced in the spleen of op/op (CSF1-deficient) mice (79).
The alteration of the gene expression profile in the spleen of
Csf1r-deficient rats is consistent with the immunohistochemistry
(IHC) data and indicates almost complete loss of the marginal
zone macrophage populations. These cells, and the related Ag
capture cells in the subcapsular sinus of lymph nodes, were also
depleted in op/op mice (47). Genes that were less spleen specific,
but are nevertheless Csf1r dependent (e.g., those in cluster 13 and
30), may be shared by macrophages of the marginal zone and red
pulp or specifically associated with red pulp macrophages.
Csf1r2/2 rats had no microglia detected by staining for IBA1 in
the brain and retina or in flow cytometry profiles of brain digests
(Figs. 8D–G, 9A). This observation was strongly supported by the
network analysis of gene expression in the four brain regions
shown in Fig. 10B. Cluster 10 (Supplemental Table I) provides a
list of 107 rat microglia-enriched genes that have been previously
published as expressed in microglia from mouse (21, 39, 40, 80,
81) and human (81, 82). Cluster 10 also includes 18 of the top 35
genes downmodulated in the brains of mice treated with a CSF1R
kinase inhibitor to deplete microglia (83). As expected, Csf1r was
almost undetectable in the homozygotes and was the only tran-
script that was also reproducibly reduced, by 40–50%, in the
heterozygous mutants, in all brain regions. Expression of Cx3cr1,
as well as cathepsin S (Ctss), the enzyme required for CX3CL1
cleavage (84), was also almost completely ablated, to the same
extent as Csf1r. Microglia-associated transcripts are of particular
interest given the emerging consensus that these cells are central
players in the pathologic condition of Alzheimer disease. Genes
including Csf1r and others within cluster 10, including Trem2,
C1q, Tyrobp, Abi3, and Spi1, are associated with disease suscep-
tibility (85–87).
Many known macrophage-associated transcripts were less af-
fected by Csf1r mutation, including Cd14, Csf2ra, Mertk, Fcgr2a
(CD32), Stab1, Msr1, Marco, Gpr84, Icam1, Clec7a, and several
TLR (Tlr2,4,8,9,11) (average 25% less expression; Supplemental
Table I). Among macrophage-expressed transcription factors, Spi1
(PU.1) was reduced by around 75%, but Irf8, Cebpa, Cebpb,
Runx1, Tfec, and Stat5A, all of which were readily detectable and
are expressed by microglia in the mouse (39, 41), were reduced
by ,37%. One interpretation is that these transcripts are more
highly expressed in the nonmicroglial macrophage population,
which is also less Csf1r dependent. The CD45hi brain macro-
phage population in rats were isolated and characterized by Ford
et al. (88). They were larger than microglia, with a lower
nucleus/cytoplasm ratio. A subset expressed MHC-II; notably,
aside from RT1-DMb, the expression of MHC-II genes (RT1-
DMa, RT1-Da, RT1-Db1, RT-1DB2, RT1-DOb) was not affected
by the Csf1r mutation. There was no detectable reduction in
lysosome/endosome-associated genes (e.g., Gpnmb, Ctsb, Lipa,
Tcirg1) that in mice are very strongly enriched in macrophages
and microglia compared with total brain (see www.biogps.org).
An alternative interpretation is that the loss of microglial
endocytic activity is compensated by increased activity in other
nonmacrophage cells.
Few impacts on overall brain architecture are shared with the
Csf1r knockout mouse (27). There was little overt phenotype and
specifically no impact on the olfactory bulb, where the mouse
mutation had the greatest effect (Fig. 8B). A recent study de-
scribed a specific microglial population associated with myeli-
nation in the brain in the postnatal period (89). These cells were
proposed to be the major source of IGF1 required for myelina-
tion. The loss of these cells could explain the minor deficiency of
myelination and myelination-associated transcripts (Figs. 8C, 9B)
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observed in the mutant rats. However, in the gene expression
profiles of rat brain regions, there was no deficiency in Igf1
mRNA associated with the Csf1r mutation. Similarly, microglia
have been considered an important source of brain-derived neu-
trotrophic factor (BDNF), although conditional microglial de-
pletion did not reduce the total level of Bdnf mRNA in the mouse
cortex or hippocampus (90). Bdnf mRNA was not reduced in the
Csf1r mutant rat brain. Presumably, the other cellular sources of
these trophic factors can compensate for the absence of micro-
glia. It remains to be seen whether the loss of microglia produces
the alterations in synaptic proteins and synaptic plasticity
observed in mouse microglia depletion studies (90, 91). Microglia
in mice have been associated with the outgrowth of dopaminergic
neurons, and their depletion produced an imbalance in dopami-
nergic innervation of the striatum (92). In the striatum of Csf1r-
deficient rats (Supplemental Table I), we observed a 30–40%
increase in mRNA encoding dopamine receptors (Drd1, 2, and 3),
the dopamine transporter Slc41a3, and other genes correlated with
dopamine receptor expression across brain regions, Gnal, Dgkb,
Pcp4l1, Kcna, and Tac1 (93). More subtle brain phenotypes may
emerge from further investigation. The advantage of the rat model
is that these phenotypes can be studied in adult animals in the
absence of gross changes in brain architecture. The flow cytometry
analysis and gene expression profiling indicate that there is no
compensatory monocyte recruitment or inflammatory cytokine
production in the Csf1r2/2 brain, consistent with the absence of
circulating monocytes. Monocyte recruitment is the hallmark of
brain pathologic conditions (38, 94) and has been observed in
other models of microglial deficiency (40). We suggest that the
impact of the loss of the neuroprotective functions of microglia in
the Csf1r2/2 rat may be mitigated by the absence of monocytes.
The human disease ALSP [formerly known as hereditary diffuse
leukoencephalopathy with spheroids (95)] is associated with mu-
tations affecting conserved amino acids in the kinase domain of
CSF1R (96), which are likely to have a dominant-negative impact
on signaling by forming inactive heterodimers with the wild
type receptor (8). Fifty-eight different mutations have been
described in ALSP patients (7), and within the human exome
database (exac.broadinstitute.org), there are a further 38 variants,
each identified only as a singleton, that affect amino acids con-
served from humans to chickens. One report claimed that the
disease could be associated with haploinsufficiency arising from a
frame-shift mutation (7), but their data indicate .50% loss of
CSF1R protein in the brains of these patients. Chitu and col-
leagues (97) have characterized Csf1r+/2 inbred mice as a model
for ALSP. Like these authors, we found that there is no dosage
compensation for loss of one Csf1r allele, which is surprising
because CSF1 signaling regulates Csf1r mRNA levels (98).
However, despite the lack of dosage compensation, we have found
no significant impact of the Csf1r heterozygous mutation on gene
expression in the adult brain (Supplemental Table I). We have
maintained heterozygous mutant rats for more than 12 months and
observed no overt phenotype. Accordingly, the impact of
dominant-acting mutations in patients is likely to depend in part
upon the level of expression of the other allele and on the activity
of the compensatory mechanisms that permit relatively normal
brain function when microglial differentiation is compromised.
In overview, analysis of Csf1r2/2 rats highlights selective im-
pacts of the mutation on macrophage populations and clear dif-
ferences in the cell populations affected and the pleiotropic
consequences compared with mutant mice. The effect of Csf1
mutation in mice on macrophages and osteoclast populations is
gradually corrected with age. The macrophage phenotype can be
corrected with exogenous GM-CSF (CSF2), but endogenous CSF2
is not required (99). Conversely, mutation of Flt1 prevents the age-
dependent development of osteoclasts (100). As noted above, one
major difference between rats and mice is that rat macrophages
themselves express high levels of Csf1 mRNA. This explains the
loss of Csf1 mRNA in the spleen of Csf1r mutant rats. In the brain
of rats, Csf1 and Il34 were both highly expressed and not notably
region specific. The Csf1r mutation did not reduce the level of
expression, suggesting that microglia are not the major source. We
suggest that differences between the rodent species derive from
differences in expression or function of alternative growth factors
that can compensate for the lack of Csf1r. Although female Csf1r
mutant rats appear infertile, hormone-dependent expression of
CSF2 and other factors by the uterus (101) might also mitigate the
impact of the Csf1r mutation on macrophage numbers and func-
tion in females relative to males.
The increased longevity and plethora of phenotypes found in
Csf1r2/2 rats provide a unique model for studying the role of
CSF1R during development and adulthood, the functions of
microglia, and other tissue macrophage populations and the mo-
lecular basis for adult onset disease associated with human CSF1R
mutations. Many of the macrophage phenotypes are shared be-
tween mice and rats, so the differences mainly lie in the relative
redundancy of macrophages in developmental processes in the two
species.
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